Total Payments
$8,700
2024 Payments
$2,329
Companies
40
Transactions
498
Medicare Patients
2,255
Medicare Billing
$217,203
Payment Breakdown by Category
Food & Beverage$8,676 (99.7%)
Education$23.42 (0.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,676 | 496 | 99.7% |
| Education | $23.42 | 2 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,427 | 44 | $0 (2024) |
| ABBVIE INC. | $1,356 | 97 | $0 (2024) |
| Novo Nordisk Inc | $828.50 | 36 | $0 (2024) |
| Amgen Inc. | $725.93 | 64 | $0 (2024) |
| Lilly USA, LLC | $529.38 | 29 | $0 (2024) |
| GlaxoSmithKline, LLC. | $509.12 | 45 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $437.71 | 24 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $284.56 | 12 | $0 (2024) |
| Merck Sharp & Dohme LLC | $264.82 | 18 | $0 (2023) |
| IDORSIA PHARMACEUTICALS US INC | $224.40 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,329 | 125 | AstraZeneca Pharmaceuticals LP ($709.64) |
| 2023 | $2,090 | 108 | ABBVIE INC. ($434.58) |
| 2022 | $2,511 | 141 | Novo Nordisk Inc ($508.27) |
| 2021 | $1,770 | 124 | AstraZeneca Pharmaceuticals LP ($292.99) |
All Payment Transactions
498 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: DIABETES | ||||||
| 12/18/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $6.98 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/18/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $2.11 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/17/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/12/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: Cardio-renal | ||||||
| 12/05/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $1.38 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/03/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: Inflammation | ||||||
| 11/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $30.58 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/21/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Insomnia | ||||||
| 11/21/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $8.11 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: Cardio-renal | ||||||
| 11/18/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $46.89 | General |
| Category: GI | ||||||
| 11/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Respiratory | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: RESPIRATORY | ||||||
| 10/28/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: RESPIRATORY | ||||||
| 10/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: Cardio-renal | ||||||
| 10/22/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $107.95 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/22/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $11.90 | General |
| Category: RESPIRATORY | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $86.36 | General |
| Category: Respiratory | ||||||
| 10/17/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 274 | 697 | $94,438 | $32,190 |
| 2022 | 13 | 386 | 787 | $104,539 | $32,443 |
| 2021 | 18 | 757 | 2,041 | $237,931 | $73,463 |
| 2020 | 18 | 838 | 2,234 | $274,661 | $79,107 |
Total Patients
2,255
Total Services
5,759
Medicare Billing
$217,203
Procedure Codes
61
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 76 | 246 | $49,836 | $15,685 | 31.5% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 44 | 251 | $20,620 | $9,748 | 47.3% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 22 | 44 | $9,900 | $1,990 | 20.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 12 | 12 | $2,195 | $1,246 | 56.8% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2023 | 18 | 18 | $4,500 | $1,204 | 26.8% |
| 95921 | Testing of autonomic nervous system function and heart rate response to deep breathing | Office | 2023 | 16 | 16 | $3,200 | $885.52 | 27.7% |
| 97760 | Training in the use of orthopedic device for arm, leg and/or trunk, each 15 minutes | Office | 2023 | 16 | 19 | $1,539 | $478.42 | 31.1% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 19 | 30 | $1,050 | $370.50 | 35.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 13 | 13 | $343.20 | $191.23 | 55.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 23 | $560.63 | $169.31 | 30.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 14 | 14 | $420.00 | $133.28 | 31.7% |
| 93040 | Electrocardiogram (ecg) 1 to 3 leads with review by physician | Office | 2023 | 11 | 11 | $275.00 | $89.21 | 32.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 102 | 336 | $69,552 | $21,356 | 30.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 41 | 41 | $9,061 | $4,394 | 48.5% |
| 99315 | Nursing facility discharge day management, 30 minutes or less | Facility | 2022 | 47 | 80 | $11,280 | $2,459 | 21.8% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2022 | 26 | 78 | $2,730 | $958.22 | 35.1% |
| 99335 | Established patient custodial care facility, group care, or assisted living visit, typically 25 minutes | Office | 2022 | 20 | 27 | $4,941 | $897.61 | 18.2% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2022 | 16 | 16 | $560.00 | $501.01 | 89.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 12 | $1,692 | $478.32 | 28.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 19 | 19 | $475.00 | $467.00 | 98.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 24 | 46 | $1,472 | $358.74 | 24.4% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 24 | 24 | $816.00 | $352.98 | 43.3% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2022 | 25 | 26 | $390.00 | $160.36 | 41.1% |
| 81003 | Automated urinalysis test | Office | 2022 | 14 | 27 | $800.00 | $56.09 | 7.0% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 16 | 55 | $770.00 | $3.38 | 0.4% |
About Arbus Locklear, PAC
Arbus Locklear, PAC is a Physician Assistant healthcare provider based in Lumberton, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2005. The National Provider Identifier (NPI) number assigned to this provider is 1982697355.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Arbus Locklear, PAC has received a total of $8,700 in payments from pharmaceutical and medical device companies, with $2,329 received in 2024. These payments were reported across 498 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($8,676).
As a Medicare-enrolled provider, Locklear has provided services to 2,255 Medicare beneficiaries, totaling 5,759 services with total Medicare billing of $217,203. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Lumberton, NC
- Active Since 08/31/2005
- Last Updated 04/07/2010
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1982697355
Products in Payments
- VRAYLAR (Drug) $748.12
- FARXIGA (Drug) $633.77
- Otezla (Drug) $484.12
- Kerendia (Drug) $437.71
- BREZTRI (Drug) $421.97
- TRELEGY ELLIPTA (Drug) $406.20
- AIRSUPRA (Drug) $371.75
- Ozempic (Drug) $348.70
- Linzess (Drug) $284.56
- MOUNJARO (Drug) $269.77
- UBRELVY (Drug) $261.36
- BELSOMRA (Drug) $236.45
- QUVIVIQ (Drug) $224.40
- LINZESS (Drug) $211.50
- JARDIANCE (Drug) $206.06
- NURTEC ODT (Drug) $192.44
- Saxenda (Drug) $167.15
- KRYSTEXXA (Biological) $166.73
- CAPLYTA (Drug) $161.82
- VOQUEZNA (Drug) $138.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Lumberton
Meredith Stocklin, Pa-C, PA-C
Physician Assistant — Payments: $5,964
Physician Assistant $5,964
Barry Graham, Pa-C, PA-C
Physician Assistant — Payments: $2,153
Physician Assistant $2,153
Mrs. Jennifer Taylor, Pa-C, PA-C
Physician Assistant — Payments: $1,740
Physician Assistant $1,740
Mrs. Victoria Locklear, Pa-C, PA-C
Physician Assistant — Payments: $1,399
Physician Assistant $1,399
Grace Davis
Physician Assistant — Payments: $1,244
Physician Assistant $1,244
Mr. Donald Metzger, Pa, PA
Physician Assistant — Payments: $1,238
Physician Assistant $1,238